FDA
-
-
-
-
-
-
-
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business Update
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Appoints Cary Claiborne as CEO
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Provides Regulatory and Development Update
-
-
-
-
-
-
-
Adial Pharmaceuticals Announces Amendment to License Agreement with the University of Virginia Licensing & Ventures Group
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

